PURPOSE: To evaluate the efficacy of irradiation of internal mammary nodes (IMN) on 10-year overall survival in breast cancer patients after mastectomy. METHODS AND PATIENTS: This multicenter phase 3 study enrolled patients with positive axillary nodes (pN+) or central/medial tumors with or without pN+. Other inclusion criteria were age <75 and a Karnofsky index ≥70. All patients received postoperative irradiation of the chest wall and supraclavicular nodes and were randomly assigned to receive IMN irradiation or not. Randomization was stratified by tumor location (medial/central or lateral), axillary lymph node status, and adjuvant therapy (chemotherapy vs no chemotherapy). The prescribed dose of irradiation to the target volumes was 50 Gy...
Background: Existing data on adding internal mammary nodal irradiation (IMNI) to the regional nodal ...
The purpose of the study was to analyze the 10-year outcomes after breast-conserving surgery with el...
BACKGROUND AND PURPOSE: The multicentre EORTC 22922/10925 trial (ClinicalTrials.gov, NCT00002851) wa...
PURPOSE: To examine the effect of internal mammary node irradiation (IMNI) on disease-free survival...
Background and objective: The internal mammary lymph nodes (IMN) have been recognized as a potential...
PURPOSE: It is unknown whether irradiation of the internal mammary lymph nodes improves survival in ...
BACKGROUND: 10-year results from several studies showed improved disease-free survival and distant m...
BACKGROUND: The effect of internal mammary and medial supraclavicular lymph-node irradiation (region...
Background: It is important to continually reevaluate the risk/benefit calculus of internal mammary ...
Purpose: This study was designed to determine the optimum radiotherapy technique for internal mammar...
Background: 10-year results from several studies showed improved disease-free survival and distant m...
PURPOSE: To test the difference in treatment outcome between breast-conservation surgery with radiat...
PURPOSE: Internal mammary lymph node (IMN) involvement is associated with poor prognosis in breast c...
The purpose of this study is to assess the value of internal mammary node irradiation (IMNI) in pati...
Abstract Background Various randomized trials have demonstrated that postmastectomy radiotherapy (RT...
Background: Existing data on adding internal mammary nodal irradiation (IMNI) to the regional nodal ...
The purpose of the study was to analyze the 10-year outcomes after breast-conserving surgery with el...
BACKGROUND AND PURPOSE: The multicentre EORTC 22922/10925 trial (ClinicalTrials.gov, NCT00002851) wa...
PURPOSE: To examine the effect of internal mammary node irradiation (IMNI) on disease-free survival...
Background and objective: The internal mammary lymph nodes (IMN) have been recognized as a potential...
PURPOSE: It is unknown whether irradiation of the internal mammary lymph nodes improves survival in ...
BACKGROUND: 10-year results from several studies showed improved disease-free survival and distant m...
BACKGROUND: The effect of internal mammary and medial supraclavicular lymph-node irradiation (region...
Background: It is important to continually reevaluate the risk/benefit calculus of internal mammary ...
Purpose: This study was designed to determine the optimum radiotherapy technique for internal mammar...
Background: 10-year results from several studies showed improved disease-free survival and distant m...
PURPOSE: To test the difference in treatment outcome between breast-conservation surgery with radiat...
PURPOSE: Internal mammary lymph node (IMN) involvement is associated with poor prognosis in breast c...
The purpose of this study is to assess the value of internal mammary node irradiation (IMNI) in pati...
Abstract Background Various randomized trials have demonstrated that postmastectomy radiotherapy (RT...
Background: Existing data on adding internal mammary nodal irradiation (IMNI) to the regional nodal ...
The purpose of the study was to analyze the 10-year outcomes after breast-conserving surgery with el...
BACKGROUND AND PURPOSE: The multicentre EORTC 22922/10925 trial (ClinicalTrials.gov, NCT00002851) wa...